Ocrelizumab (Anti-CD20)

Ask supplier a question | View on supplier's website

Ocrelizumab (Anti-CD20) is a recombinant humanized monoclonal IgG1 antibody that selectively targets CD20 antigen present on B-cells. It is used to treat relapsing remitting multiple sclerosis. MW:145.5 KD.

Supplier	Selleck Chemicals
Product #	A2561
Sku #	A2561-1mg*5
Pricing	1mg*5, $1690.00

Feedback